Published in Aliment Pharmacol Ther on February 01, 1996
Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology (2008) 3.04
Diagnosis of Zollinger-Ellison syndrome: increasingly difficult. World J Gastroenterol (2012) 0.85
Treatment of Zollinger-Ellison syndrome. World J Gastroenterol (2005) 0.80
Catching the Zebra: Clinical Pearls and Pitfalls for the Successful Diagnosis of Zollinger-Ellison Syndrome. Dig Dis Sci (2017) 0.75
Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med (1999) 3.21
Osteoporosis after spinal cord injury. J Orthop Res (1992) 2.70
Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. Ann Intern Med (1996) 2.51
A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med (2000) 2.09
Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology (1995) 2.03
Normal appearance of arachnoid granulations on contrast-enhanced CT and MR of the brain: differentiation from dural sinus disease. AJNR Am J Neuroradiol (1996) 1.98
Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach. Ann Intern Med (1993) 1.94
The genomic context of natural killer receptor extended gene families. Immunol Rev (2001) 1.92
Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas. J Nucl Med (1999) 1.92
Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore) (2000) 1.88
Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study. Ann Intern Med (1989) 1.78
Localization and surgical treatment of occult insulinomas. Ann Surg (1990) 1.76
How antidepressants work: new perspectives on the pathophysiology of depressive disorder. Br J Psychiatry (2001) 1.72
Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study. Ann Surg (1992) 1.71
Reflux esophagitis in patients with Zollinger-Ellison syndrome. Gastroenterology (1990) 1.68
Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Endoscopy (2010) 1.60
Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol (1999) 1.59
Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors. Dig Dis Sci (1989) 1.57
Gastrinomas: localization by means of selective intraarterial injection of secretin. Radiology (1990) 1.56
Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome. Proc Natl Acad Sci U S A (1998) 1.55
Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas. Cancer (1999) 1.52
p38 kinase is activated in the Alzheimer's disease brain. J Neurochem (1999) 1.50
Characteristics of cell lines established from human gastric carcinoma. Cancer Res (1990) 1.49
Use of omeprazole in patients with Zollinger-Ellison syndrome. Dig Dis Sci (1991) 1.49
Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome. Ann Surg (1986) 1.44
Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation. Genes Chromosomes Cancer (1998) 1.43
Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells. Proc Natl Acad Sci U S A (1980) 1.43
Zollinger-Ellison syndrome: current concepts and management. Ann Intern Med (1983) 1.42
Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome. Ann Surg (1998) 1.42
Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors. Cancer Res (1998) 1.40
Interactions of COOH-terminal fragments of cholecystokinin with receptors on dispersed acini from guinea pig pancreas. J Biol Chem (1982) 1.37
Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors. J Biol Chem (1997) 1.33
Interaction of bombesin and litorin with specific membrane receptors on pancreatic acinar cells. Proc Natl Acad Sci U S A (1978) 1.30
Chronic mild stress and sucrose consumption: validity as a model of depression. Physiol Behav (1996) 1.29
The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay. Brain Res (1981) 1.27
Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation. Ann Surg (1988) 1.27
Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci U S A (1992) 1.26
A synthetic peptide that is a bombesin receptor antagonist. Nature (1984) 1.24
Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera. N Engl J Med (1985) 1.24
Regional osteoporosis in women who have a complete spinal cord injury. J Bone Joint Surg Am (2001) 1.23
Redox regulatory mechanisms of cellular signal transduction. Arch Biochem Biophys (2000) 1.23
Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor. Clin Cancer Res (1999) 1.23
Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management. Gastroenterology (1997) 1.23
Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome. Am J Med (1998) 1.22
Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann Surg (1994) 1.21
CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones. Am J Physiol (1999) 1.19
Detection of duodenal gastrinomas by operative endoscopic transillumination. A prospective study. Gastroenterology (1990) 1.18
Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria. Carcinogenesis (2000) 1.18
Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. J Intern Med (1998) 1.15
A prospective analysis of the frequency, location, and curability of ectopic (nonpancreaticoduodenal, nonnodal) gastrinoma. Surgery (1997) 1.15
Location, incidence, and malignant potential of duodenal gastrinomas. Surgery (1991) 1.15
Prospective study of the ability of computed axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome. Gastroenterology (1987) 1.15
Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. Ann Surg (2001) 1.14
Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1. Surgery (1995) 1.14
Gastric secretion in Zollinger-Ellison syndrome. Correlation with clinical expression, tumor extent and role in diagnosis--a prospective NIH study of 235 patients and a review of 984 cases in the literature. Medicine (Baltimore) (2001) 1.14
Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann Surg (1986) 1.13
Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery (2001) 1.11
Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion. Ann Intern Med (1984) 1.10
Neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors. Am J Physiol (1989) 1.10
The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology (1997) 1.10
Gastrointestinal dysfunction in systemic mastocytosis. A prospective study. Gastroenterology (1988) 1.09
Cushing's syndrome in patients with the Zollinger-Ellison syndrome. N Engl J Med (1986) 1.09
Receptors and cell activation associated with pancreatic enzyme secretion. Annu Rev Physiol (1986) 1.09
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology (2016) 1.09
Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res (1997) 1.08
Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type I. Am J Med (1994) 1.08
Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form. J Clin Endocrinol Metab (2001) 1.08
Retrograde amnesia and memory reactivation in rats with ibotenate lesions to the hippocampus or subiculum. Q J Exp Psychol B (1994) 1.08
Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists. Proc Natl Acad Sci U S A (1981) 1.08
Selective venous sampling for gastrin to localize gastrinomas. A prospective assessment. Ann Intern Med (1986) 1.08
A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas. Ann Surg (1993) 1.08
Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes. Eur J Pharmacol (1998) 1.07
The bombesin receptor subtypes have distinct G protein specificities. J Biol Chem (1999) 1.07
Gastrinomas: comparison of MR imaging with CT, angiography, and US. Radiology (1989) 1.07
Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome. Gastroenterology (1985) 1.07
Mammalian bombesin receptors. Med Res Rev (1995) 1.06
Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res (1992) 1.06
Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study. Surgery (1987) 1.05
Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study. Gastroenterology (1989) 1.05
Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome. Gastroenterology (1992) 1.04
Prospective study of the use of intraarterial secretin injection and portal venous sampling to localize duodenal gastrinomas. Surgery (1992) 1.04
Interaction of CCK with pancreatic acinar cells. Trends Pharmacol Sci (1989) 1.03
Actions of a newly isolated intestinal peptide PHI on pancreatic acini. Am J Physiol (1981) 1.02
Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors. J Clin Endocrinol Metab (2000) 1.02